We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 46

Data protection in Canada: Court of Appeal confirms narrow approach

  • Torys LLP
  • -
  • Canada
  • -
  • January 30 2013

On January 18, 2013, the Federal Court of Appeal (FCA) released its decision in Takeda Canada Inc. v. The Minister of Health and Attorney General of

Ontario court confirms generic drug manufacturers not entitled to unjust enrichment

  • Torys LLP
  • -
  • Canada
  • -
  • January 22 2013

On January 15, 2013, the Ontario Superior Court of Justice (Ontario Court) granted a motion for partial summary judgment in Apotex Inc. v. Abbott

Canada’s PAAB releases updated Code of Advertising Acceptance

  • Torys LLP
  • -
  • Canada
  • -
  • December 7 2012

The Pharmaceutical Advertising Advisory Board (PAAB) has released a revised version of its Code of Advertising Acceptance

Producers to manage pharmaceuticals and sharps returned by consumers

  • Torys LLP
  • -
  • Canada
  • -
  • November 2 2012

On October 1, 2012, Collection of Pharmaceuticals and Sharps Responsibilities of Producers regulation (O. Reg. 29812) came into force

Health Canada to list authorized clinical trials online

  • Torys LLP
  • -
  • Canada
  • -
  • October 25 2012

On October 18, 2012, Health Canada issued a news release and subsequent Drugs and Health Products Notice announcing that it will create a web-based list of clinical trials authorized by Health Canada

Health Canada announces intent to develop a framework for orphan drug approval

  • Torys LLP
  • -
  • Canada, USA
  • -
  • October 5 2012

On October 3, 2012, Health Canada issued a press release announcing that it will develop a framework for the marketing approval of drugs to treat rare life-threatening, seriously debilitating or serious chronic rare diseases that are commonly referred to as "orphan drugs."

Ontario case on product liability shows the immense scope of a class action trial

  • Torys LLP
  • -
  • Canada
  • -
  • July 5 2012

In a highly anticipated decision released on June 26, 2012, the Ontario Superior Court of Justice ruled in favour of the defendants in Andersen v. St. Jude Medical, Inc., Ontario’s first medical product liability class action trial

Product liability litigation: bar raised for class action certification?

  • Torys LLP
  • -
  • Canada
  • -
  • May 10 2012

In a decision released May 7, 2012, Justice Caroline Horkins of the Superior Court of Ontario has refused to certify a proposed class proceeding in a pharmaceutical product liability claim (Martin et al. v. Astrazeneca Pharmaceuticals PLC et al

Canada to change the regulation of “food-like" natural health products

  • Torys LLP
  • -
  • Canada
  • -
  • April 24 2012

On April 17, 2012, Health Canada announced that it will classify and transition all "food-like" natural health products (NHPs) to the regulatory framework that governs the sale of food products in Canada

Legal - or what?

  • Torys LLP
  • -
  • Canada, USA
  • -
  • April 17 2012

"How can you manage issues arising from regulations and legal requirements in different jurisdictions."